Retinopathy of prematurity (ROP) appears to be a multifactorial disease, the prevention of which is probably impossible even with the most accurate methods of blood-gas monitoring and oxygen restrictions. The oxidative processes and consequent formation of free radicals are probably influenced by the availability of various antioxidants in the immature retina. Bilirubin, the end product of haem catabolism, has recently been regarded as a potential physiological antioxidant. In order to test the suggestion as to the possible effect of bilirubin in reducing the incidence of ROP a retrospective study was undertaken of the medical records of 151 neonates born between 1984 to 1988 who weighed less than 1500 g. Of these, 78 had various degrees of ROP, whereas 73 had no ROP and served as a control group. The daily mean bilirubin values were analysed in accordance with gestational age and birth weight as well as the severity of ROP, and the results were compared with those obtained for the control group. The results showed no correlation between bilirubin levels and severity of ROP in all subgroups of gestational age and birth weight. These findings indicate that there is no apparent protective effect of bilirubin on the development of ROP.
During the past few decades there have been dramatic advances in the care of critically ill newborn babies, resulting in the greatly improved survival of infants with extremely low birth weights. Phelps' estimated that 30-35% of infants with a birth weight of 1000 g or less will develop cicatricial retinopathy of prematurity, with 8% becoming blind. As ROP appears to be a multifactorial disease,2"8 its complete prevention, even by the most accurate methods of monitoring blood gases and oxygen restriction, has been assumed to be impossible. However, the search for possible influencing factors con- tinues.
Current data indicate that oxidative processes in the tissues may be of vital importance in the initiation of the disease." These oxidative pro- The daily mean bilirubin values were very similar in infants with ROP as compared with those without ROP (p>005) (Fig 1) . Further- bilirubin levels may be insufficient for the antioxidative potential effect of bilirubin. Another explanation of the undetected antioxidative effect of bilirubin may be due to the fact that this report reviewed bilirubin levels in the first 14 days of life, a period in which bilirubin is known to be physiologically high. As ROP tends to not appear before 6 weeks of age, it is possible that the time interval between the decrease to normal bilirubin levels and the appearance ofROP is long enough to diminish its protective effect in preventing the disease. 
